| Clinical Symptom Patterns | Dengue | Chikungunya | Zika |
|---|---|---|---|
| Incubation period (days) | 4-10 | 3-7 | 3-12 |
| Asymptomatic infection (%) | 50-80 | 3-28 | 80 |
| Fever | +++ | +++ | + |
| Headache | +++ | ++ | + |
| Conjunctivitis | - | - | ++ |
| Arthralgias | ++ | +++ | + |
| Myalgias | ++ | + | + |
| Skin rash | ++ | ++ | +++ |
| Peripheral oedema | - | - | ++ |
| Haemorrhagic manifestations | ++ | (+) | - |
| Circulatory collapse/ shock | + | - | - |
| Thrombocytopenia | ++ | ++ | - |
| Lymphadenopathy | ++ | ++ | + |

| Test | First serum sample† | Second serum sample‡ | Interpretation |
|---|---|---|---|
| Dengue IgM IIFT | negative | negative | negative |
| Dengue IgG IIFT | 1:20 | 1:5120 | cross-reactivity |
| Dengue NS1-Ag | negative | negative | negative |
| Chikungunya IgM ELISA | negative | ND | negative |
| Chikungunya IgM IIFT | ND | negative | negative |
| Chikungunya IgG IIFT | ND | negative | negative |
| Zika IgM IIFT | negative | 1:640 | positive |
| Zika IgG IIFT | 1:20 | 1:5120 | positive |
| Zika RT-PCR | positive | ND | positive |

†obtained 6 days after onset of symptoms
‡obtained 7 days after the first serum sample
IIFT: Indirect Immunofluorescence Test; RT-PCR: real-time reverse transcription polymerase chain reaction; ELISA: Enzyme-linked Immunosorbent Assay; ND: not done.